| PERIOD ENDING | 4-Oct-09 | 5-Jul-09 | 5-Apr-09 | 31-Dec-08 | | Total Revenue | 19,344 | 20,219 | 20,077 | 18,103 | | Cost of Revenue | 10,783 | 11,082 | 11,370 | 10,730 | | | Gross Profit | 8,561 | 9,137 | 8,707 | 7,373 | | | Operating Expenses | | Research Development | 521 | 588 | 603 | 633 | | Selling General and Administrative | 5,607 | 5,509 | 6,029 | 4,922 | | Non Recurring | (2) | 2 |
-
| 70,376 | | Others | 853 | 871 | 871 | 790 | | | | Total Operating Expenses | 6,979 | 6,970 |
-
| 76,721 | | | | Operating Income or Loss | 1,579 | 2,167 | 1,204 | (69,348) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5 | 7 | 9 | 44 | | Earnings Before Interest And Taxes | 1,587 | 2,174 | 1,213 | (69,304) | | Interest Expense | 362 | 156 | 129 | 323 | | Income Before Tax | 1,225 | 2,018 | 1,084 | (69,627) | | Income Tax Expense | 426 | 747 | 477 | (7,172) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 799 | 1,271 | 607 | (62,455) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 799 | 1,271 | 607 | (62,455) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $799 | $1,271 | $607 | ($62,455) |
|
0.01% Nasdaq 
0.04 (2.88%) 
Income Statement
